Clinical Trial: The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss(R) SCB' Versus 'SeQuent(R) Please NEO' in Patients With Coronary ISR

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159087) titled 'The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss(R) SCB' Versus 'SeQuent(R) Please NEO' in Patients With Coronary ISR' on June 27.

Brief Summary: The objective of this study is to evaluate the safety and effectiveness of Genoss(R) SCB by comparing in-segment late lumen loss (LLL) to the control group (SeQuent(R) Please NEO) at 6 months in patients with coronary stent-in-stent restenosis (ISR) with a reference vessel diameter of 2.0-4.0 mm.

Study Start Date: Feb. 19

Study Type: INTERVENTIONAL

Condition: Coronary Arterial Disease (CAD)

Intervention: DEVICE: Sirolimus Coated PTCA Balloon Catheter(Genoss(R) SC...